Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 3, 2012, Pages 216-220

  Mizukami, Kazuhiro ^a   Murakami, Kazunari ^a   Hirashita, Yuka ^a   Hisamatsu, Akari ^a   Ogawa, Ryo ^a   Uchida, Masahiro ^a   Nakagawa, Yoshifumi ^a   Okimoto, Tadayoshi ^a   Kodama, Masaaki ^a   Fujioka, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Adaptation; Aspirin; Placebo; Rebamipide; Symptoms

Indexed keywords

ACETYLSALICYLIC ACID; OMEPRAZOLE; PLACEBO; REBAMIPIDE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BORBORYGMUS; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONSTIPATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION DISORDER; DEFECATION URGENCY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; ERUCTATION; FLATULENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HARD FECES; HEARTBURN; HUMAN; HUMAN EXPERIMENT; HUNGER PAIN; LOOSE FECES; LOW DRUG DOSE; MALE; NAUSEA; NORMAL HUMAN; PILOT STUDY; PRESCRIPTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

EID: 84868603616     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-27     Document Type: Article

References (30)

1. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American heart association science advisory and coordinating committee. Circulation 2002; 106: 388-391. (Pubitemid 34778969)
2. Lanas A, García-Rodríguez LA, Polo-Tomás M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009; 104: 1633-1641.
3. Cayla G, Collet JP, Silvain J, Thiefin G, Woimant F, Montalescot G. Prevalence and clinical impact of Upper Gastrointestinal Symptoms in subjects treated with low dose aspirin: the UGLA survey. Int J Cardiol 2012; 156: 69-75.
4. Inadomi JM, McIntyre L, Bernard L, Fendrick AM. Step-down from multipleto single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003; 98: 1940-1944. (Pubitemid 37185787)
5. Tack Jan, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol 2005; 39 (Suppl 3): S211-S216. (Pubitemid 44638349)
6. Bjarnason I, Thjodleifsson B. Gastrointestinal toxicity of non-steroidal antiinflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology (Oxford) 1999; 38 (Suppl 1): 24-32. (Pubitemid 29505040)
7. Kim HK, Kim JI, Kim JK, et al. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers. Dig Dis Sci 2007; 52: 1776-1782.
8. Banan A, Fitzpatrick L, Zhang Y, Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic Biol Med 2001; 30: 287-298. (Pubitemid 32126448)
9. Yoshikawa T, Naito Y, Tanigawa T, Kondo M. Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneim-Forsch/Drug Res 1993; 43: 363-366. (Pubitemid 23093246)
10. Murakami K, Okajima K, Uchiba M, et al. Rebamipide attenuates indomethacin- induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats. Dig Dis Sci 1997; 42: 319-325. (Pubitemid 27112977)
11. Tanigawa T, Watanabe T, Ohkawa F, et al. Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase. J Clin Biochem Nutr 2011; 48: 149-153.
12. Kawai T, Yamagishi T, Goto S. Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period. J Atheroscler Thromb 2009; 16: 155-163.
13. Nishida U, Kato M, Nishida M, et al. Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin. World J Gastroenterol 2011; 17: 226-230.
14. Kawai T, Takagi Y, Fukuzawa M, Yamagishi T, Goto S. The role of trefoli factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study. J Clin Biochem Nutr 2011; 49: 136-140.
15. Chitapanarux T, Praisontarangkul OA, Lertprasertsuke N. An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors. Dig Dis Sci 2008; 53: 2896-2903.
16. Yoshida N, Kamada K, Tomatsuri N, et al. Management of recurrence of symptoms of gastroesophageal reflux disease: synergistic effect of rebamipide with 15 mg lansoprazole. Dig Dis Sci 2010; 55: 3393-3398.
17. Yamamoto T, Isono A, Mishima Y, et al. Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. J Clin Biochem Nutr 2010; 47: 27-31.
18. Niwa Y, Nakamura M, Miyahara R, et al. Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-contolled double-blind cross-over study. Digestion 2009; 80: 260-266.
19. Svedlund J, Sjödin I, Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-134. (Pubitemid 18054672)
20. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-687. (Pubitemid 23231987)
21. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046-1052.
22. Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988; 95: 327-333.
23. Nishida U, Kato M, Nishida M, et al. Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration. J Clin Biochem Nutr 2011; 48: 245-250.
24. Niwa Y, Nakamura M, Ohmiya N, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008; 43: 270-276. (Pubitemid 351650037)
25. Fujimori S, Takahashi Y, Gudis K, et al. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. J Gastroenterol 2011; 46: 57-64.
26. Fujimori S, Seo T, Gudis K, et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009; 69: 1339-1346.
27. Mizukami K, Murakami K, Abe T, et al. Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol 2011; 17: 5117-5122.
28. Park SH, Cho CS, Lee OY, et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled Trial-STORM STUDY. J Clin Biochem Nutr 2007; 40: 148-155.
29. Akamatsu T, Nagaya T, Ichikawa S, et al. Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects. J Clin Biochem Nutr 2010; 47: 256-260.
30. Gwee KA, Hwang JE, Ho KY, Yeoh KG, Lum CF, Ang PK. In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population. J Clin Gastroenterol 2008; 42: 134-138.